|
|
|
|
| We're ready to help usher your next drug into market! 2025's first Outsourced Pharma Capacity Update provides a unique, virtual experience and the details necessary to find a CDMO for your specific timeline, volume, and production needs. Join us the last week of January as we draw the curtains on the industry's best and give you complimentary VIP access to the resources available to support your success. Learn more and register to save your seat! |
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | Agentic AI is the next artificial-intelligence iteration for the biopharma industry. It propels prediction to autonomous decision-making. It can usher in transformative efficiencies to CDMOs. If you've day-dreamed of more effective external-support, this may be a ticket to that destination. | |
|
|
|
|
|
|
The High Potent Market And The Role Of A Specialist CDMO | By Dr Rebecca Coutts, Ph.D., PCI Pharma Services | Safe handling of HPAPIs is complex and the associated regulatory requirements are growing. Discover how leveraging a CDMO can ensure treatments reach patients faster, safely, and cost-effectively. |
|
|
|
Spray Drying Biologics: An Alternative To Freeze Drying | White Paper | By Dr. Richard Johnson, Upperton Pharma Solutions | Uncover how innovative drying technologies can enhance the stability and efficacy of biologics, ensuring successful outcomes in this rapidly growing sector of the pharmaceutical industry. |
|
|
Improving Solubility With Spray Drying | Q&A | Lonza | Gain expert insights into how to develop a spray dried powder formulation and scale it from early feasibility studies to commercial manufacturing. |
|
|
|
|
|
|
|
Solid Form Services | Lonza | We have defined work flows to assess and select solid forms in a cost and time efficient manner that meets the needs of each individual program. |
|
|
|
|
Biomarker Development And Assessment | Worldwide Clinical Trials Lab Services | Whether used for primary or secondary endpoints or in exploratory research, our seasoned scientists provide scientifically robust support to ensure the successful application of biomarker assays. |
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|